Study Details

Study Purpose

The purposes of the study is to determine the efficacy and tolerability of a topically applied formulation of rosemary extract containing carnosic acid on the cessation and prevention of eczema and pruitis (itchiness) in people with either active eczema or who are eczema-prone.

Study Duration

Total 5 Visits Over 56 Days (8 Weeks)
Screening and Product Application Phase

Study Schedule

General Screening

Group 1: September 15 and Group 2: September 16

Medical Screening

N/A

Study Visit(s)

Visit 1 (Day 0) [G1: September 15 / G2: September 16] APPROX. 3.5 HOURS
Informed Consent, Visual Assessment, Instrumental Evaluations, Application on Site, Questionnaires, Imaging, Swabbing, Instructions
Visit 2 (Day 7) [G1: September 22 / G2: September 23] APPROX. 2 HOURS
Visual Assessment, Instrumental Evaluations, Questionnaires, Imaging, Swabbing
Visit 3 (Day 14) [G1: September 29 / G2: September 30] APPROX. 2 HOURS
Visual Assessment, Instrumental Evaluations, Questionnaires, Imaging, Swabbing
Visit 4 (Day 28) [G1: October 13 / G2: October 14] APPROX. 2 HOURS
Visual Assessment, Instrumental Evaluations, Questionnaires, Imaging, Swabbing
Visit 5 (Day 56) [G1: November 10 / G2: November 11] APPROX. 2 HOURS
Visual Assessment, Instrumental Evaluations, Questionnaires, Imaging, Swabbing

Follow-Up Visit(s)

N/A

Other Notes

Bring valid ID

$50 referral incentive

Eczema-prone people must have had at least 1 eczema flare up per year